Related Experiment Video
Updated: Feb 14, 2026
08:32
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
Published on: February 22, 2019
7.6K
[Malignant neoplasms in the neonate]
Marta Zapata-Tarrés1, Daniel Ibarra-Ríos2, Irma Viridiana Cruz-Rodríguez3
1Servicio de Oncología, Instituto Nacional de Pediatría, México D.F., México.
Boletin Medico Del Hospital Infantil De Mexico
|February 9, 2018
Summary
Pediatric cancers differ from adult cancers, with survival rates up to 70% for certain tumors. Early diagnosis and tailored multidisciplinary treatment, often involving surgery, are crucial for improving outcomes in childhood cancer.
Area of Science:
- Pediatric Oncology
- Neonatal Neoplasms
- Childhood Cancer Characteristics
Context:
- Pediatric cancers present unique challenges compared to adult malignancies.
- Neonatal tumors, particularly solid types like teratomas and neuroblastomas, show increasing incidence.
- Hematopoietic, central nervous system, and sympathetic/mesenchymal tissues are primary sites affected.
Purpose:
- To highlight the distinct features of childhood cancers.
- To emphasize the role of early detection and specialized treatment in improving survival rates.
- To underscore the importance of modified treatment protocols for newborns.
Summary:
- Childhood cancer survival reaches 70% for some tumors, varying by type.
- Solid neonatal tumors are increasing, while central nervous system tumors and leukemias remain stable.
- Ultrasonography detects up to 70% of fetal anomalies; multidisciplinary care is vital.
Impact:
- Timely diagnosis and treatment significantly improve survival for pediatric cancer patients.
- Understanding unique newborn physiology is key to effective, low-toxicity cancer treatment.
- Surgery remains a primary intervention, necessitating specialized pediatric care approaches.
